The CXCL12/CXCR4/ACKR3 Axis in the Tumor Microenvironment: Signaling, Crosstalk, and Therapeutic Targeting

Martine J Smit1, Géraldine Schlecht-Louf2, Maria Neves2,3,4,5

  • 1Department of Medicinal Chemistry, Amsterdam Institute of Molecular and Life Sciences (AIMMS), Faculty of Science, Vrije Universiteit Amsterdam, 1081 HZ Amsterdam, Netherlands;

Insights

The CXCL12/CXCR4/ACKR3 axis drives cancer through complex signaling and immune cell interactions. Targeting this axis, alongside receptor tyrosine kinases or immune cells, offers promising therapeutic strategies for cancer treatment.

Area of Science:

  • Oncology
  • Molecular Biology
  • Immunology

Background:

  • The chemokine pathway involving CXCL12, CXCR4, and ACKR3 is upregulated in various tumors and the tumor microenvironment (TME).
  • The precise mechanisms by which this axis influences cancer pathogenesis remain incompletely understood.
  • This axis plays a role in tumor progression through intricate signaling networks and immune cell modulation.

Purpose of the Study:

  • To elucidate the multifaceted roles of the CXCL12/CXCR4/ACKR3 axis in cancer development.
  • To explore the axis's interactions with signaling pathways and the TME.
  • To review current and novel therapeutic strategies targeting this axis.

Main Methods:

  • Review of existing literature on the CXCL12/CXCR4/ACKR3 axis in cancer.
  • Analysis of molecular mechanisms, including canonical and non-canonical signaling.
  • Examination of crosstalk with receptor tyrosine kinases (RTKs) and immune cells within the TME.

Main Results:

  • The CXCL12/CXCR4/ACKR3 axis impacts diverse cancer cell signaling pathways.
  • Bidirectional crosstalk exists between this axis, RTKs, and other TME components.
  • The axis influences immune cell infiltration, which can promote tumor progression.

Conclusions:

  • Targeting the CXCL12/CXCR4/ACKR3 axis is a key strategy in cancer therapy.
  • Combined targeting of RTKs and the CXCL12/CXCR4/ACKR3 axis presents a viable multitargeted approach.
  • Modulating this axis in conjunction with immune cell inhibition or activation holds significant therapeutic potential.

Related Concept Videos

The Tumor Microenvironment02:17

The Tumor Microenvironment

Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
7.4K
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
11.0K
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
7.0K
Intracellular Signaling Affects Focal Adhesions01:17

Intracellular Signaling Affects Focal Adhesions

Integrins act both as extracellular input receivers and as intracellular processing activators. As their name suggests, integrins are entirely integrated into the membrane structure. Their hydrophobic membrane-spanning regions interact with the phospholipid bilayer's hydrophobic region. These membrane receptors provide extracellular attachment sites for effectors like hormones and growth factors. They activate intracellular response cascades when their effectors are bound and active.
Some...
3.3K
Canonical Wnt Signaling Pathway02:54

Canonical Wnt Signaling Pathway

The gene encoding the main signaling molecules of the Wnt signaling pathways (the Wnt proteins) was discovered almost four decades ago by Nüsslein-Volhard and Wieschaus. They identified and originally named the gene "wingless" (wg) after a phenotype discovered during their landmark genetic screen in Drosophila for body pattern defects. At around the same time, another researcher named Harold Varmus found that a murine tumor virus activates the mammalian wg homolog, Int-1, which...
10.0K
Non-Canonical Wnt Signaling Pathways01:41

Non-Canonical Wnt Signaling Pathways

Wnt is a zygotic effect gene that is expressed during very early embryonic development. It regulates various processes in animals starting from early development through the adult stage, such as organogenesis in the embryo and maintenance of neuronal and blood stem cells. Wnt proteins can induce a wide variety of intracellular pathways depending upon the specific abilities of different Wnt ligands to form a complex with shared and cognate receptors in the presence of different co-receptors. The...
8.1K